Young, urban and poor women in Puerto Rico are highly vulnerable to substance dependency and suffer most in the opioid crisis. Limited government data invisibilizes their experiences.

Get a Sample Copy of this Report: The report covers qualitative and quantitative analyses of market size and shares for historical and forecast periods ... For example, in February 2021, Avrio Health, ...

A very influential family with deep political and financial connections to the Sacklers — the owners of Purdue Pharma — the family and company who are named as the driving force in the opioid ...

The Sackler dynasty, owners of Purdue Pharma and makers of powerful prescription painkiller OxyContin, has agreed to pay up to $7.4 billion of their own money to settle claims over its role in ...

The deal would also end the Sacklers’ control of Purdue. The fate of the company itself, which remains in Chapter 11 bankruptcy since filing in 2019, will be determined by a board of trustees ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Purdue Pharma and its owners have agreed to pay up to $7.4 billion in a new settlement to lawsuits regarding their role in the opioid epidemic, the attorneys general of over a dozen states announced.